ResearcherIstituto Nazionale Tumori IRCCS "Fondazione G. Pascale"Active in the last 2 years
Alessandro Ottaiano
Matched on ORCID iD 0000-0002-2901-3855; OpenAlex author ID A5071949598. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 10
2017: 2 papers · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper
Papers 3
- Identification of Tissue miRNA Signatures for Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/cancers16040824↗
- Gemcitabine mono-therapy versus gemcitabine plus targeted therapy in advanced pancreatic cancer: a meta-analysis of randomized phase III trials. Co-author DOI 10.1080/0284186x.2017.1288922↗
- Nab-Paclitaxel and Gemcitabine in Advanced Pancreatic Cancer: The One-year Experience of the National Cancer Institute of Naples. Co-author DOI 10.21873/anticanres.11539↗
Closest collaborators
The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Chiara Carmen Miceli · 1 shared paper, 2024 · strength 0.16
- Carlo Caputo · 1 shared paper, 2024 · strength 0.16
- Luca Pompella · 1 shared paper, 2024 · strength 0.16
- Fortunato Ciardiello · 1 shared paper, 2024 · strength 0.16
- Ferdinando De Vita · 1 shared paper, 2024 · strength 0.16
- Donatella Coradduzza · 1 shared paper, 2024 · strength 0.16
- Michele Caraglia · 1 shared paper, 2024 · strength 0.16
- Gabriella Misso · 1 shared paper, 2024 · strength 0.16
- Antonio Avallone · 2 shared papers, 2017 · strength 0.14
- Paper Gemcitabine mono-therapy versus gemcitabine plus targeted therapy in advanced pancreatic cancer: a meta-analysis of ran… DOI 10.1080/0284186x.2017.1288922↗
- Paper Nab-Paclitaxel and Gemcitabine in Advanced Pancreatic Cancer: The One-year Experience of the National Cancer Institute … DOI 10.21873/anticanres.11539↗
- Salvatore Tafuto · 2 shared papers, 2017 · strength 0.14
- Paper Gemcitabine mono-therapy versus gemcitabine plus targeted therapy in advanced pancreatic cancer: a meta-analysis of ran… DOI 10.1080/0284186x.2017.1288922↗
- Paper Nab-Paclitaxel and Gemcitabine in Advanced Pancreatic Cancer: The One-year Experience of the National Cancer Institute … DOI 10.21873/anticanres.11539↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.